Search for: "West v. West, et al." Results 661 - 680 of 1,220
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
28 Jan 2023, 7:32 am
 Pix Credit hereESG, has been driven by the private sector and intensely debated in the context of privately ordered responsible business conduct standards, and formed part of a rich debates among market actors and public international organizations about the role and nature of so-called non-financial siclosure in genmeral, and sustainability and climate related factors in decision making. [read post]
11 May 2022, 1:48 pm by Mary Whisner
Either way, you might like to have some resources handy to help you understand the context of the case.Good Overviews  Laurie Sobel et al., Abortion at SCOTUS: Dobbs v. [read post]
30 Sep 2018, 6:28 pm by Georgialee Lang
McCorkell), deceased, et al., 2016 CanLII 34017 SCC) National Alliance, a white supremacy group in West Virginia, was gifted a collection of valuable coins from ancient Rome and Greece, an antique Iranian sword, and other artifacts and investments said to be worth a minimum of $250,000 and as much as $1 million dollars. [read post]
7 Oct 2014, 11:52 am by Gregorgy Dell
AT&T West Disability Benefits Program et. al, was seeking disability benefits under an ERISA plan administered by Sedgwick. [read post]
2 Sep 2014, 2:23 am
Wyndham Worldwide Corp., et al., Defendants, Civil Action No. 13-1887 (ES), United States District Court, D. [read post]
2 Sep 2014, 2:23 am
Wyndham Worldwide Corp., et al., Defendants, Civil Action No. 13-1887 (ES), United States District Court, D. [read post]
17 Feb 2017, 1:34 pm by Bill Marler
In total, 134 people with hepatitis A have been reported from nine states: Arkansas (1), California (1), Maryland (12), New York (3), North Carolina (1), Oregon (1), Virginia (107), West Virginia (7), and Wisconsin (1). [read post]
11 May 2011, 4:54 am by Marie Louise
ARUP: Genetic testing patents found to be anticipated and in violation of Lilly written description requirement (Holman’s Biotech IP Blog) (Patent Docs) (Patently-O) US: FDA gets the ball rolling on biosimilar/interchangeable biological product user fee program; proposal gives a hat tip to PDUFA while acknowledging the nascent state of the industry (FDA Law Blog) (Patent Docs) Products Citalopram – UK Patents Court disapproving of EPO’s approach to assessment of novelty: Lundbeck… [read post]